Hayato Nagasawa

Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.

Hideto Kameda, Hayato Nagasawa, Hiroe Ogawa et al. · PubMed · 2005 · 230 citations

High Dose Psl, Immunosuppressive Therapy, Immunology +11

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)

Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka et al. · Annals of the Rheumatic Diseases · 2016 · 109 citations · Full text

Time‐dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis

Ryoko Sakai, Yukiko Komano, Michi Tanaka et al. · Arthritis Care & Research · 2012 · 89 citations

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study

Tsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano et al. · Lara D. Veeken · 2011 · 89 citations · Full text

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Ryoko Sakai, Soo‐Kyung Cho, Toshihiro Nanki et al. · Arthritis Research & Therapy · 2015 · 72 citations · Full text

Rheumatoid Disorder, Rheumatology, Epidemiology +11